First, protein tyrosine phosphatase (PTP1B) is a major glucose-homeostasis and energy-metabolism regulator, thus regarded as an attractive drug target for therapeutic intervention in type 2 diabetes and obesity [5]. Here, PTPN1 is linked to type 2 diabetes mellitus.